Lyvispah
Payments companies reported to CMS as associated with Lyvispah. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Lyvispah, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Lyvispah
These are the largest totals companies reported as associated with Lyvispah. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jennifer O'Malley | Palo Alto, CA | Neurology With Special Qualifications In Child Neurology | $333.67 |
| Norman Gordon | East Providence, RI | Neurology (Psychiatry & Neurology) | $248.75 |
| Dennis Aumentado | North Smithfield, RI | Neurology (Psychiatry & Neurology) | $244.48 |
| Casilda Balmaceda | New York, NY | Neurology (Psychiatry & Neurology) | $244.28 |
| Jose Cabassa | New York, NY | Neurology (Psychiatry & Neurology) | $231.68 |
| Mehrdad Golzad | Elmhurst, NY | $218.04 | |
| Suneel Wadhwani | Porterville, CA | Family Medicine | $205.06 |
| Naeem Sarfraz | Fairfield, CT | Internal Medicine | $194.22 |
| Igal Staw | Fairfield, CT | Pulmonary Disease | $194.22 |
| Peter Mcallister | Fairfield, CT | Neurology (Psychiatry & Neurology) | $178.81 |
Prescribed Lyvispah?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.